PharmaEssentia Reaffirms Commitment to Reliable Interferon Therapy Access
January 6, 2025
PharmaEssentia, a global biopharmaceutical company, reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global concerns about drug